共 31 条
- [21] Utility of a modified age-adjusted Charlson Comorbidity Index in predicting cause-specific survival among patients with gastric cancer EJSO, 2021, 47 (08): : 2010 - 2015
- [29] IS THERE A BENEFIT OF LUNG STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN OUR PATIENTS WITH MULTIPLE CO-MORBIDITIES?: AGE-ADJUSTED CHARLSON COMORBIDITY INDEX (ACCI) AS A PREDICTOR OF SURVIVAL IN MEDICALLY INOPERABLE EARLY STAGE NON SMALL CELL LUNG CANCER PATIENTS TREATED WITH DEFINITIVE RADIOTHERAPY JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S544 - S545
- [30] Comparison of 4 Previously Established, but Highly Different Comorbidity Scores (Kaplan Feinstein Index [KF], Charlson-Comorbidity Index [CCI], Satariano Index [SI], Hematopoietic cell transplantation-specific comorbidity index [HCT-CT]) Identifies the KF and HCT-CI as Most Relevant, but Use of An Easily Applied 3-Risk-Factor (KLeber)-Score Suggests to Even More Effectively Predict Progression-Free- and Overall-Survival Differences in Multiple Myeloma (MM) Patients (pts). BLOOD, 2009, 114 (22) : 714 - 715